Tencent has led a series E-plus round for Taimei as part of a capital influx totalling $212m, with SoftBank's SBCVC unit also among the investors.
China-based clinical research software provider Taimei Technology has disclosed RMB1.5bn ($212m) in funding including a $132m series E-plus round led by internet group Tencent, DealStreetAsia reported on Friday citing an announcement on WeChat.
The total also includes a series E round led by hedge fund manager Tiger Global Management, some details of which were revealed in January this year, and the rounds also featured SoftBank China Venture Capital (SBCVC), a corporate venturing vehicle for telecommunications firm SoftBank.
Morningside Venture…
